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1108 Abstracts October 2014calf veins that previously were not visualized and seven were seen in
femoral veins or calf veins that previously were visualized and did not
have clot (Table).
Conclusions: Nonvisualized calf veins are common in DUS imag-
ing. Almost half of patients with nonvisualized veins on the initial DUS
imaging had successful visualization on subsequent DUS scans. Lower
body weight, whole leg swelling, single vein nonvisualization, and sin-
gle limb nonvisualization on the initial DUS scan were associated with
successful visualization on subsequent DUS scans. Of patients with
nonvisualized veins on the initial DUS scan, 4.8% go on to develop
VTE, and 8.8% of patients who have subsequent DUS scans are found
to have DVT. When the initial DUS scan is unable to visualize calf
veins, a repeat DUS scan may be useful to identify new or initially un-
seen DVT.Table. Factors associated with development of subsequent venous
thromboembolism (VTE) or successful calf vein visualization on
subsequent duplex ultrasound (DUS) scans after nonvisualization of calf
veins on the initial DUS scan
Factor
Development of
subsequent VTE
Successful
visualization of
calf veins on
subsequent DUS
P value,
c2 or t-testa
P value,
c2 or t-testa
Demographics
Gender 1.000 .187
Age .440 .726
Height .884 .861
Weight .580 .0497
Body mass index .532 .056
Well’s score criteria
Active malignancy .210 .125
Recent surgery or trauma .105 .832
Whole leg swelling .984 .025
Calf swelling 1.000 .058
Pitting Edema .513 1.000
Prior DVT 1.000 .578
Collateral superﬁcial vein 1.000 .453
Paralysis, cast or, immobilization .783 .344
Pain along deep veins .435 1.00
Alternative diagnosis .533 .650
Well’s score .833 .071
Initial DUS
Single or multiple
nonvisualized veins
.826 < .001
One or both lower extremities 1.000 .021
Reason for nonvisualization
Bandage .626 .294
Body habitus .502 .157
Wound 1.000 .453
Edema .822 .063
Multiple .610 1.000
Reason for DUS
Concern for PE .103 .042
Lower extremity swelling .132 .045
Abnormal laboratory values 1.000 .453
Pain .718 .448
Other 1.000 .546
Multiple .264 .184
Postimaging anticoagulation .410 1.000
DVT, Deep vein thrombosis; PE, Pulmonary embolism.
aP < .05 is statistically signiﬁcant.Author Disclosures: J. C. Henry: None; D. Strosberg: None; S.
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Postoperative Transfusion Is Associated With a Dramatic Increase in
30-Day Morbidity and Mortality in Patients Undergoing Major
Vascular Surgery
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dergoing major vascular surgery. Prior studies suggest an association be-
tween blood transfusion and increased morbidity and mortality among
patients undergoing cardiac surgery. The effect of transfusion on patients
undergoing vascular surgery has been poorly deﬁned.
Methods: We examined data from a large multicenter quality
improvement vascular surgical registry of all patients undergoing elective
or urgent open peripheral arterial disease (PAD) procedures, endovascular
aneurysm repair (EVAR), or open abdominal aortic aneurysm (AAA)
repair between 2012 and 2013. Emergency cases, carotid endarterec-
tomy, and carotid artery stenting were excluded. Univariate and multivar-
iate logistic regression modeling was used to identify the effect of
transfusion on outcomes and predictors of transfusion. All regression
models had a Hosmer-Lemeshow P > .05 and area under receiver oper-
ating characteristic curve of >0.8, conﬁrming excellent goodness of ﬁt
and discrimination.
Results: Our study population comprised 2946 patients who un-
derwent open PAD procedures (n ¼ 1744), open AAA (n ¼ 175),
or EVAR (n ¼ 1027) at 22 hospitals. The overall transfusion rate
was 18%, at a median nadir hemoglobin of 7.7 g/dL. Adjusting for
major covariates, including preoperative anemia (hemoglobin <12 g/
dL), medications (including antiplatelets and anticoagulants), demo-
graphics, and comorbidities, transfusion was independently associated
with myocardial infarction (odds ratio [OR], 10.1; 95% conﬁdence in-
terval [CI], 5.2-19), death (OR, 3.8; 95% CI, 2.1-7), surgical site
infection (OR, 2.2; 95% CI, 1.3-3.5), and pneumonia (OR, 8.9; 95%
CI, 4.1-19). Independent factors predicting transfusion included female
gender (OR, 2.2; 95% CI, 1.7-2.7), body mass index (OR, 1.005; 95%
CI, 1.002-1.01), preoperative anemia (OR, 3.1; 95% CI, 2.4-3.8),
congestive heart failure (OR, 1.4; 95% CI, 1.1-1.9), clopidogrel (OR,
1.7; 95% CI, 1.3-2.2), open AAA repair (OR, 10.1; 95% CI, 6.5-
15.5), open bypass (OR, 3.1; 95% CI, 1.9-5.2), and urgent procedures
(OR, 1.4; 95% CI, 1.01-1.8).
Conclusions: Postoperative transfusion in vascular surgical patients is
independently associated with increased 30-day mortality and morbidity.
The risk of adverse cardiovascular events, including myocardial infarction,
was worsened rather than improved with transfusion. These data suggest
the need for a prospective comparative hemoglobin threshold study in
vascular surgical patients.
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Objectives: Current percutaneous vascular interventions to treat se-
vere atherosclerosis induce mechanical or thermal injury to the vessel
wall, which stimulates the development of neointimal hyperplasia and re-
sults in restenosis. The objective of this study was to develop a paradigm-
shifting methodology to reduce plaque burden without inducing trauma
to the arterial wall. We hypothesized that a digestion solution tailored to
the components of atherosclerotic plaques would effectively digest pla-
ques in situ.
Methods: After IRB approval, carotid plaques from endarterec-
tomies were collected, sectioned (200-mg segments), and exposed to
our digestion solution (10 mg/mL collagenase types I, III, IV, V,
and 10mM CaCl2) with ultrasonic sonication (20 kHz) at 42C, pH
7.2, for 20 minutes. Specimens were weighed at baseline and every
10 minutes. Superﬁcial femoral and popliteal arteries were harvested
from limb amputations and cut into 3-cm sections. The lumen was
exposed to our digestion solution or phosphate-buffered saline
(PBS), with or without ultrasonic sonication, for 1 hour or 20 mi-
nutes. Arterial segments were mounted in parafﬁn, sectioned, and
stained with hematoxylin and eosin, van Gieson, and Masson tri-
chrome. Plaque and medial area from ﬁve sections spaced 0.2 mm
apart were analyzed for each artery.
Results: First, we evaluated our optimized digestion solution
with sonication on the harvested human plaques. We found that our
therapy reduced plaque mass by 75% 6 6% at 15 minutes and by
86% 6 3% at 30 minutes vs PBS with sonication (12% 6 4% at 20 mi-
nutes; P < .05). Next, we evaluated the efﬁcacy of our digestion so-
lution on intact arteries. Our digestion solution with sonication
resulted in 92% reduction of the plaque area compared with PBS
with sonication at 1 hour (31%; P < .05). Medial area was constant
across all groups. Notably, the internal elastic lamina was intact after
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ion reduced plaque area by 46% (P < .05) compared with 2% without
sonication, which was insigniﬁcant.
Conclusions: Our therapy can safely and effectively reduce athero-
sclerotic plaque burden ex vivo without damaging the arterial wall. Optimi-
zation of this therapy will allow for shorter, more clinically relevant digestion
times. Ultimately, this therapy shows promise as a novel atraumatic method
to reduce atherosclerotic lesions in situ.
Author Disclosures: Z. Wang: None; Z. M. Emond: None; C. E.
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Objectives: Over the past decade, the use of endovascular grafts for
endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has
increased signiﬁcantly. With the increased use of endovascular techniques,
there has been a higher volume of endovascular complications. In some in-
stances, it is not feasible or necessary to excise the entire endovascular graft,
suggesting that partial excision may be indicated. However, there is not
enough literature to support the efﬁcacy of partial graft excision after
EVAR. This study was designed to evaluate our institution’s outcomes of
partial explant patients who underwent EVAR.
Methods: A retrospective analysis of partially explanted EVARs
requiring late explantation (>1 month) from 1999 to 2012 was per-
formed using a database. Each patient’s postoperative computed tomog-
raphy (CT) scan was compared with the most recent follow-up CT and
subsequently evaluated using computer software to measure graft location
within the aorta to determine if any graft migration occurred. Indication
for graft removal, type of excision, length of follow-up, and mortality
were reviewed.
Results: Between 1999 and 2012, 22 patients had a partial late
EVAR explantation. Of these 22 patients, there were four patients
with proximal components remaining, 17 patients with distal compo-
nents remaining, and one patient with both proximal and distal com-
ponents left. Nine of the 22 (41%) had postoperative and follow-up
CT imaging, of which none of these patients had migration of their
remaining graft components. The average length of follow-up in these
nine patients was 25.9 months. Nine of the 22 patients (41%) were
lost to follow-up before having two postoperative CT scans. Four of
the 22 patients (18%) died secondary to postoperative infection, shock,
and organ failure before being discharged from the hospital after par-
tial EVAR explantation.
Conclusions: Partial EVAR explantation is an option in instances
where total excision of an endovascular aortic graft would not be tolerated.
All of our partial late EVAR explantation patients who had postexplant CT
imaging and follow-up CT imaging demonstrated no migration of their
endovascular grafts. Further follow-up in patients with partial late EVAR
explantation is necessary to determine if partial graft excision after EVAR
is a durable treatment option in the future.
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Lyden: Consulting fee from Cook, Medtronic, and Trivascular; R. L.
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Objectives: This study evaluated the safety and effectiveness of ultra-
sound accelerated thrombolysis in acute pulmonary embolism (PE).
Methods: A retrospective study of 45 patients (25 male, 20 fe-
male) was performed to evaluate treatment of acute PE at a single
center from January 2011 to December 2013. All patients were diag-
nosed with computed tomography (CT) or VQ scan and had hemody-
namic instability or right heart strain evidenced by right ventricular
dilatation, septal deviation, or hypokinesis by echocardiography or
CT. EkoSonic catheters (EKOS Corporation, Bothell, Wash) were
placed into the affected pulmonary arteries. Thirteen patients received
an average bolus of 30 mg tissue plasminogen activator with an
average infusion dose of 21.3 mg (range, 15-48 mg) over 14 hours
(range, 8-21 hours).Results: Hypotension (systolic blood pressure <100 mmHg) was
present in 13 patients, with 100% resolution by treatment completion.
Tachycardia (heart rate >100 beats/min) was present in 26 patients
and resolved in 92% by treatment completion. The average heart rate
for all patients decreased from 109 to 77 beats/min over the treatment
period. Direct pulmonary artery pressure measurement showed an
average decrease of 21.5 mm Hg. Postprocedure echocardiography
demonstrated complete resolution of cardiac dysfunction in 64%. There
were no deaths through 90 days of follow-up and no major periproce-
dural bleeding events.
Conclusions: The current study demonstrates the safety and effec-
tiveness of using ultrasound accelerated thrombolysis to treat acute pulmo-
nary embolism.
Author Disclosures: C. Laurich: None; P. Kelly: None; A. Santos:None;
A. Vandenhull: None.
Contemporary Outcomes for Carotid Interventions in the State of
Michigan
Charles J. Shanley, MD,1 Yeo J. Park, PhD,2Michael J. Boros, MD,3 Hitinder
S. Gurm, MD,2 Paul M. Grossman, MD,2 Jeffrey R. Rubin, MD,4 Peter K.
Henke, MD5. 1Beaumont Health System; 2University of Michigan Health
System; 3Munson Medical Center; 4Detroit Medical Center; and 5University
of Michigan Health System, Detroit, Mich
Objectives: CREST documented similar outcomes for carotid artery
stenting (CAS) and carotid endarterectomy (CEA). This study evaluated
contemporary outcomes for patients undergoing carotid intervention in
Michigan.
Methods: We evaluated the outcomes for consecutive carotid inter-
ventions at 22 hospitals in Michigan between January 1, 2012, and
December 31, 2013, using data derived from a prospective, statewide qual-
ity improvement registry. Outcomes of interest included the occurrence of
any transient ischemic attack/stroke, ipsilateral stroke, myocardial infarction
(MI), death, and composite end points of stroke/death and stroke/MI/
death. Data were stratiﬁed on the basis of preoperative symptom status.
The Cochran-Mantel-Haenszel test was used to determine the common
odds ratio from stratiﬁed binary variables, and propensity score matching
(PSM) was used to account for demographic differences between CAS
and CEA patients.
Results: Of 3136 patients undergoing carotid intervention, CEA
was performed in 2482 patients (79.1%) and CAS in 654 (20.9%). For
patients undergoing CEA, the rates of in-hospital transient ischemic
attack (TIA)/stroke, stroke/death, and stroke/MI/death were 1.9% (n
¼ 47), 2.3% (n ¼ 57), and 2.7% (n ¼ 68). For patients undergoing
CAS, the rates of in-hospital TIA/stroke, stroke/death, and stroke/
MI/death were 5.5% (n ¼ 36), 6.3% (n ¼ 41), and 6.7% (n ¼ 44).
When stratiﬁed on the basis of preoperative symptom status, the rate
of TIA/stroke was signiﬁcantly higher for CAS than for CEA in both
asymptomatic (5.1% vs 1.5%; odds ratio [OR], 3.6; 95% conﬁdence inter-
val [CI], 1.9-6.7) and symptomatic (6.0% vs 2.7%; OR, 2.3; 95% CI,
1.2-4.3) patients (common OR, 2.8; 95% CI, 1.8-4.4; P < .001).
Follow-up data were available at 30 days for 2838 (90.4%) and at 1
year for 1131 (36.1%). The rates of subsequent stroke, MI, and death
were not different between CAS and CEA at 30 days or 1 year. In pro-
pensity matched analysis (n ¼ 1308), no differences in the rate of stroke,
MI, or death were observed.
Conclusions: In Michigan, CAS is associated with increased rates
of in-hospital TIA/stroke as well as the composite end points of
stroke/death and stroke/MI/death. The complication rate was espe-
cially high among patients with asymptomatic disease. Patient-speciﬁc
and clinical decision-making factors appear to explain the observed dif-
ferences in outcomes, emphasizing the importance of patient selection
in CAS.
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Objectives: Renal artery stenting has not proven to be efﬁcacious for
the treatment of renovascular hypertension (ASTRAL, CORAL). This study
provides evidence using Doppler ﬁndings and ﬂuid mechanics that the
